Ankin Law News
Friday, May 10, 2013: Josh Rudofi will be filing an Appellate Brief in Dig Right In Landscaping v. Jose Nunez on behalf of Jose Nunez.
Wednesday, April 24, 2013: Scott Goldstein will be speaking as a guest lecturer at John Marshall Law School in the Workers Compensation class.
Wednesday, April 17, 2013: Josh Rudolfi attended Artex Risk Solutions Mock Trial at The Witt. (read more...)
November 30, 2012: Scott Goldstein of Ankin Law Office
was highlighted in a "Making Chicago Great" feature
on WCIU Channel 26 in Chicago.
November, 2012: A client of Howard Ankin knitted him a
blanket as a special thank you after a multiple
6 figure settlement.
RECENT BLOG POSTS
While there are a few hardy souls who bike to work all winter long, spring...
Have you ever been told you are not allowed to discuss your salary with co-workers?...
Under a new law, effective January 1st of this year, inline skaters and roller bladers...
Byetta, a diabetes drug, is currently being monitored by the U.S. Food and Drug Administration (FDA) because of the risk of serious side effects, including acute pancreatitis. The Chicago class action drug litigation attorneys at Ankin Law Offices have significant experience representing clients in product liability lawsuits, including class action cases and unsafe pharmaceutical litigation. If you or someone you love has experienced health problems as a result of taking the drug Byetta, our skilled Illinois unsafe pharmaceutical attorneys can help you with any product liability lawsuit you may have.
What Is Byetta?
Byetta is an injectable drug that is used to treat type 2 diabetes. Byetta is designed to control a patient’s blood sugar levels by lowering glucose levels.
What Are the Problems with Byetta?
The most common side effect associated with Byetta is acute pancreatitis, which can result in nausea, vomiting and severe abdominal pain. As of 2008, the FDA had received 30 reports of patients experiencing acute pancreatitis and 78 reports of altered kidney function after taking Byetta.
The FDA has instructed health care professionals to advise patients taking Byetta to seek immediate medical attention if they begin to experience severe and persistent abdominal pain, which could be a sign of acute pancreatitis. The FDA has also requested that Byetta’s manufacturer, Amylin Pharmaceuticals, include a “black box” warning on the product’s label warning patients of the risk of acute pancreatitis and altered kidney function.
What Is the Status of Byetta?
The FDA is continuing to monitor the safety and efficacy of Byetta. If you or a loved one has experienced acute pancreatitis, altered kidney function or other health problem after taking Byetta, you may have a personal injury cause of action. The knowledgeable Illinois unsafe pharmaceuticals attorneys at Ankin Law Offices have experience representing clients in a variety of personal injury cases, including class actions for dangerous and defective products.
Contact one of our skilled Chicago unsafe pharmaceuticals attorneys to schedule a free consultation if you have experienced health problems as a result of taking Byetta.
You Might Also Be Interested In: